Related Experiment Video
Updated: Jun 2, 2026

Murine Full-thickness Skin Transplantation
Published on: January 2, 2017
Current approaches to skin cancer management in organ transplant recipients
Meena K Singh1, Jerry D Brewer
1Mayo School of Graduate Medical Education, College of Medicine, Mayo Clinic, Rochester, MN, USA.
Abstract:
Approximately 225,000 people are living with organ transplants in the United States. Organ transplant recipients have a greater risk of developing skin cancer, including basal cell carcinoma, squamous cell carcinoma, and malignant melanoma, with an approximately 250 times greater incidence of squamous cell carcinoma in certain transplant recipients, compared with the general population. Because skin cancers are the most common posttransplant malignancy, the resultant morbidity and mortality in these high-risk patients is quite significant.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Tumor Immunotherapy

